Table 1.
No. | Author | Pt age (years) | Pt sex | Pt Country | Clinical manifestation | Days to Dx after Ad | Dx basis | Antibiotics used prior to diagnosis | Final antibiotic regimen | Ref |
---|---|---|---|---|---|---|---|---|---|---|
1 | Drancourt et al. | 3 | M | USA | fever, headache | 24 | C + SH + HPLC | Ct + M | V + To | [3] |
2 | Pham et al. | 28 | M | USA | fever, chills, headache | 7–9 | C + 16S | Cz | V | [4] |
3 | Pham et al. | 44 | F | USA | fever, | 7–9 | C + 16S | Cz | V | [4] |
4 | Pham et al. | 54 | F | USA | fever, | 7–9 | C + 16S | L+ Imp | V | [4] |
5 | Pham et al. | 46 | F | USA | fever, chills | 7–9 | C + 16S | E | V+ Imp | [4] |
6 | Pham et al. | 60 | M | USA | fever, chills, orthostatic hypotension | 7–9 | C + 16S | At | Cd + Az | [4] |
7 | Drancourt et al. | 40 | F | France | fever, hemiparesis | 7 | C + 16S | SMZ + OF | V | [12] |
8 | Bakker et al. | 15 | M | Netherlands | fever, thumb pain | 14 | C + 16S | D | NA | [13] |
9 | Gil-Sande et al. | 61 | M | Spain | fever, urine retention, altered mental status | 20 | C + 16S | PT + G | NA | [5] |
10 | Nicodemo et al. | 55 | F | Brazil | fever, nausea | 15 | C + 16S | PT + V | Imp + Ci | [6] |
11 | Lai et al. | 58 | F | Taiwan | fever | NA | C + 16S | Imp + Ci | V | [7] |
12 | Lai et al. | 23 | M | Taiwan | fever, bone pain | NA | C + 16S | Imp | V | [7] |
13 | Lai et al. | 75 | M | Taiwan | fever | NA | C + 16S | Ci | V | [7] |
14 | Lai et al. | 30 | M | Taiwan | fever | NA | C + 16S | AC | NA | [7] |
15 | Lai et al. | 48 | M | Taiwan | fever, cough | NA | C + 16S | AC | NA | [7] |
16 | Ma et al. | 45 | M | Hong Kong | abdominal pain | 21 | C + 16S | Ca + Cz | V | [10] |
17 | Ma et al. | 61 | M | Hong Kong | NA | 13 | C + 16S | Ci + Ca + Cz | V | [10] |
18 | Ma et al. | 60 | M | Hong Kong | NA | 12 | C + 16S | Ca + Cz | Mem | [10] |
19 | Blanc et al. | 41 | F | France | eye smarting | >3 | C + 16S | NA | NA | [2] |
20 | Grisold et al. | 24 | M | Austria | fever, dyspnoea, nausea, and vomiting | NA | C + 16S | L + PT | NA | [14] |
21 | Zardawi et al. | 29 | F | Australia | mass in breast | >7 | C + 16S | NA | Te | [15] |
22 | Zampella et al. | 56 | F | USA | mass on foot | NA | C + 16S | SMZ | AC | [16] |
23 | Aoyama et al. | NA | NA | Japan | pulmonary infections | NA | C + 16S | NA | NA | [17] |
Ad admitted, C culture, Dx diagnosis, NA data not available, SH southern hybridization, HPLC high performance liquid chromatography, Pt patient, Ref reference, AC amoxicillin-clavulanate, Az azithromycin, At atreonam, Cd clindamycin, Ct ceftriaxone, Ca cefazolin, Cz ceftazidime, Ci ciprofloxacin, D doxycycline, E erythromycin, G gentamicin, Mem meropenem, Imp imipenem, L levofloxacin, M metronidazole, OF ofloxacin, PT piperacillin/tazobactam, SMZ sulfamethoxazole, To tobramycin, Te tetracycline, V vancomycin